Loading
PH
PharmaTher Holdings Ltd. Stock: price and insider trades · Canada
PharmaTher Holdings Ltd.: what insiders have been doing
PharmaTher Holdings Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEDI. Nothing new has been filed by managers of PharmaTher Holdings Ltd. in twelve months, the latest record being from 15 October 2025.
Over the whole record (from 2023), the tally stands at 36 purchases and 3 sales.
For comparison within the same sector, see the insider buying recorded at Xenon Pharmaceuticals Inc. and Vivos Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
45
Thresholds
n/a
Buy Volume
€28,749
36 ops. · all time
Sell Volume
€41,135
3 ops. · all time
Who traded when
BuySaleFabio Chianelli29 buys3 sales
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2023FY ended May 2023 · cache
CA$0.06
Analyst consensus
Income statement
EBITDA-CA$4M
Net income-CA$6.4M0.0% margin
Valuation
P/Book7.9x
Beta2.16
Balance sheet & cash
Market capCA$5M
Free Cash Flow-CA$3.2M
Profitability & ownership
ROE-76.9%
ROA-39.5%
% insiders18.7%
% institutions0.0%
Last declaration on 15 October 2025
Declarations45 total
2,000 shares@ CA$0.158.6% of flowCommon SharesTSXSEDI:4591882
Canonical exit: 13 Jan 2026 (T+90)
1,000 shares@ CA$0.1554.4% of flowCommon SharesTSXSEDI:4591883
Canonical exit: 13 Jan 2026 (T+90)
500 shares@ CA$0.3655.3% of flowCommon SharesTSXSEDI:4575203
Canonical exit: 11 Dec 2025 (T+90)
500 shares@ CA$0.375.3% of flowCommon SharesTSXSEDI:4575202
Canonical exit: 11 Dec 2025 (T+90)
500 shares@ CA$0.3455.0% of flowCommon SharesTSXSEDI:4575201
Canonical exit: 10 Dec 2025 (T+90)
1,000 shares@ CA$0.3510.1% of flowCommon SharesTSXSEDI:4575200
Canonical exit: 10 Dec 2025 (T+90)
1,000 shares@ CA$0.3710.7% of flowCommon SharesTSXSEDI:4575198
Canonical exit: 9 Dec 2025 (T+90)
500 shares@ CA$0.385.5% of flowCommon SharesTSXSEDI:4575195
Canonical exit: 7 Dec 2025 (T+90)
500 shares@ CA$0.385.5% of flowCommon SharesTSXSEDI:4575193
Canonical exit: 4 Dec 2025 (T+90)
500 shares@ CA$0.3855.6% of flowCommon SharesTSXSEDI:4575191
Canonical exit: 4 Dec 2025 (T+90)
2,500 shares@ CA$0.39528.7% of flowCommon SharesTSXSEDI:4575189
Canonical exit: 3 Dec 2025 (T+90)
500 shares@ CA$0.3850.1% of flowCommon SharesTSXSEDI:4567563
Canonical exit: 27 Nov 2025 (T+90)
2,500 shares@ CA$0.410.7% of flowCommon SharesTSXSEDI:4567558
Canonical exit: 26 Nov 2025 (T+90)
4,000 shares@ CA$0.381.1% of flowCommon SharesTSXSEDI:4567554
Canonical exit: 27 Nov 2025 (T+90)
500 shares@ CA$0.380.1% of flowCommon SharesTSXSEDI:4567564
Canonical exit: 27 Nov 2025 (T+90)
10,000 shares@ CA$0.392.8% of flowCommon SharesTSXSEDI:4567551
Canonical exit: 26 Nov 2025 (T+90)
5,000 shares@ CA$0.381.4% of flowCommon SharesTSXSEDI:4567560
Canonical exit: 27 Nov 2025 (T+90)
500 shares@ CA$0.390.1% of flowCommon SharesTSXSEDI:4567565
Canonical exit: 27 Nov 2025 (T+90)
2,500 shares@ CA$0.380.7% of flowCommon SharesTSXSEDI:4567561
Canonical exit: 27 Nov 2025 (T+90)
46,000 shares@ CA$0.7324.5% of flowCommon SharesTSXSEDI:4567547
2,500 shares@ CA$0.420.8% of flowCommon SharesTSXSEDI:4567559
Canonical exit: 26 Nov 2025 (T+90)
10,000 shares@ CA$0.3852.8% of flowCommon SharesTSXSEDI:4567550
Canonical exit: 26 Nov 2025 (T+90)
1,000 shares@ CA$0.380.3% of flowCommon SharesTSXSEDI:4567562
Canonical exit: 27 Nov 2025 (T+90)
1,000 shares@ CA$0.380.3% of flowCommon SharesTSXSEDI:4567553
Canonical exit: 26 Nov 2025 (T+90)
15,000 shares@ CA$0.394.2% of flowCommon SharesTSXSEDI:4567556
Canonical exit: 26 Nov 2025 (T+90)
25 of 45 declarations
About PharmaTher Holdings Ltd.
PharmaTher Holdings Ltd. is a company focused on developing psychedelic therapies for the treatment of psychiatric disorders. It is listed on the Toronto Stock Exchange under the symbol XTSE.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
